PharmaPark Production OÜ
PharmaPark Production OÜ is a OÜ based in Tallinn, registry code 16729463, status: active. Main activity: Manufacture of pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €7 704 571 with 114 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 7.7 mn €above 85% of companiesindustry median 234 187 € · companies in the industry: 12
- Labour taxes per employee 2 919 €above 20% of companiesindustry median 4 573 € · companies in the industry: 12
- Revenue · 2025 5.5 mn €above 88% of companiesindustry median 48 003 € · companies in the industry: 19
- Net profit margin · 2025 -94.0 %above 9% of companiesindustry median 9.8 % · companies in the industry: 15
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 7 704 571 | 337 392 | 332 772 | 114 |
| Q2 2026 | 7 004 497 | — | 300 360 | 98 |
| Q1 2026 | 5 512 398 | — | 264 838 | 94 |
| Q4 2025 | 2 567 820 | — | 247 269 | 79 |
| Q3 2025 | 593 011 | — | 247 569 | 59 |
| Q2 2025 | 1 090 496 | — | 236 612 | 62 |
| Q1 2025 | 1 321 165 | — | 220 075 | 64 |
| Q4 2024 | 2 465 121 | — | 183 952 | 59 |
| Q3 2024 | 616 261 | — | 137 811 | 52 |
| Q2 2024 | 276 216 | 34 417 | 103 588 | 29 |
| Q1 2024 | 2 490 | 37 047 | 41 380 | 20 |
| Q4 2023 | 59 056 | 9 864 | 10 960 | 11 |
| Q3 2023 | — | 7 348 | 10 068 | 6 |
| Q2 2023 | — | — | — | 4 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 5 501 298 | -5 171 670 | 2 324 595 | 25 102 911 | 15 575 445 | 63 |
| 2024 | 1 440 758 | -3 778 347 | 1 505 742 | 3 953 224 | -3 905 825 | 36 |
| 2023 | 2 052 | -129 978 | 95 207 | 87 303 | -127 478 | 3 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 8 Jul 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 13 Nov 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 2 May 2023 – 31 Dec 2023 | 27 Oct 2024 | Company’s own | e-Äriregister |
Board
- Veiko SalusteBoard member · since 2 May 2023
- Marco UuetaluBoard member · since 4 Aug 2026
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Interchemie B.V.Legal person · 2 500 €
Beneficial owners
- Anthonie Sebastiaan TesinkIndirect ownership · NLD · since 30 Sep 2025
Founders and other persons
- OÜ Eesti Farmaatsia GruppFounder · 1 000 € · 1 May 2023
Related companies
Activities (EMTAK)
- 21201Manufacture of pharmaceutical preparations Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50227602 / 9 4 Aug 2026 |
Amendment entry | In force 4 Aug 2026 |
||
| Ä 50227602 / 8 30 Dec 2025 |
Amendment entry | In force 30 Dec 2025 |
||
| Ä 50227602 / 7 29 Dec 2025 |
Second (constitutive) merger entry | In force 29 Dec 2025 |
||
| Ä 50227602 / M5 19 Dec 2025 |
Ruling to eliminate deficiencies | Deficiencies eliminated 29 Dec 2025 |
||
| Ä 50227602 / M4 23 Sep 2025 |
Refund of the state fee | In force 23 Sep 2025 |
||
| Ä 50227602 / 6 17 Sep 2025 |
Amendment entry | In force 17 Sep 2025 |
||
| K 50227602 / 5 17 Sep 2025 |
Commercial pledge deleted | In force 17 Sep 2025 |
||
| Ä 50227602 / 4 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| K 50227602 / 3 8 Aug 2023 |
Commercial pledge entered | In force 8 Aug 2023 |
||
| K 50227602 / M3 4 Aug 2023 |
Procedural ruling | 14 Aug 2023 | Deficiencies eliminated 8 Aug 2023 |
|
| Ä 50227602 / 2 24 Jul 2023 |
Amendment entry | In force 24 Jul 2023 |
||
| Ä 50227602 / M2 30 Jun 2023 |
Procedural ruling | In force 30 Jun 2023 |
||
| Ä 50227602 / M1 31 May 2023 |
Warning of compulsory dissolution | 30 Jun 2023 | Deficiencies eliminated 2 Jun 2023 |
|
| Ä 50227602 2 May 2023 |
First entry | In force 2 May 2023 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data